7U5 Stock Overview
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
BIOTON S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.82 |
| 52 Week High | zł0.89 |
| 52 Week Low | zł0.76 |
| Beta | 0.16 |
| 1 Month Change | 3.02% |
| 3 Month Change | 0.74% |
| 1 Year Change | 2.37% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 1.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7U5 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 2.4% | 0.2% | 1.6% |
| 1Y | 2.4% | -24.4% | 7.3% |
Return vs Industry: 7U5 exceeded the German Biotechs industry which returned -24.9% over the past year.
Return vs Market: 7U5 underperformed the German Market which returned 6.5% over the past year.
Price Volatility
| 7U5 volatility | |
|---|---|
| 7U5 Average Weekly Movement | 5.3% |
| Biotechs Industry Average Movement | 5.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7U5 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7U5's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 357 | Jeremy Launders | www.bioton.pl |
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A. Fundamentals Summary
| 7U5 fundamental statistics | |
|---|---|
| Market cap | €71.33m |
| Earnings (TTM) | €533.85k |
| Revenue (TTM) | €42.62m |
133.6x
P/E Ratio1.7x
P/S RatioIs 7U5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7U5 income statement (TTM) | |
|---|---|
| Revenue | zł181.64m |
| Cost of Revenue | zł108.78m |
| Gross Profit | zł72.85m |
| Other Expenses | zł70.58m |
| Earnings | zł2.28m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 17, 2024
| Earnings per share (EPS) | 0.026 |
| Gross Margin | 40.11% |
| Net Profit Margin | 1.25% |
| Debt/Equity Ratio | 9.0% |
How did 7U5 perform over the long term?
See historical performance and comparison